For example, persistent frequent urination could be related to urinary tract infections, kidney problems, or other conditions unrelated to semaglutide
With a GLP-1 in pill form for weight loss expected to be FDA-approved by years end, obesity medicine physicians said they are gearing up for higher demand and already answering questions about the anticipated new option
Environ Sci Technol 36:40074008 Messner B, Thulke O, Schaffner AR (2003) Arabidopsis glucosyltransferases with activities toward both endogenous and xenobiotic substrates
Paying attention to these early signals can help you adjust your routine before they start affecting your day
In rare cases, they may lead to more serious reactions, including pancreatitis, gallbladder issues, kidney problems, or severe gastrointestinal symptoms
According to the FDA, a biosimilar is a biological product that closely resembles an already FDA-approved reference product and shows no clinically significant differences in safety or effectiveness